Children are different from adults. Therefore, they need clinical trials that account for their specific needs in developing drugs that are proven to be effective and safe.

We work on this with passion!

The Pediatric Clinical Pharmacological Trial Center (paedKliPS) is a pediatric Early Clinical Trial Unit (PECTU) certified according to DIN EN ISO 9001:2015. paedKliPS has been conducting early clinical drug trials since 2018 in children, adolescents and (young) adults with pediatric, non-oncological diseases and is financially supported by the Dietmar Hopp Stiftung.

paedKliPS is a collaborative institution of University Children’s Hospital Heidelberg (Geschäftsführender Ärztlicher Direktor: Prof. Dr. med., Prof. h.c. mult. (RCH) Georg F. Hoffmann) and the Department of Clinical Pharmacology and Pharmacoepidemiology  (Medical Director: Prof. Dr. med. Walter E. Haefeli, FBPhS). Thus paedKliPS combines clinical pediatric expertise especially in rare diseases  with decades of experience in the GCP-compliant conduct of clinical drug trials of the early phases 0-2 including proof-of-concept studies and First Application.

Using the best infrastructure this cooperation leads to excellent recruitment rates of children and adolescents with various rare diseases in clinical trials. The group utilizes state-of-the-art conduct of complex trial protocols (incl. first-in-diseased-child) with challenging therapeutics, including gene therapy. With its network of expertise and the thematic orientation, this institution is unique in Central Europe. 

paedKliPS is also a training and continuous education center for medical and non-medical study personnel. It enables the double specialist qualification in pediatrics and adolescent medicine/clinical pharmacology. 

We are very pleased to organize challenging pediatric clinical trials with you as a Single-Point-of-Contact at the Heidelberg University Campus and to conduct those trials successfully under the motto: Together for the health of our children!

Dr. med. Kristine Chobanyan-Jürgens, Dr. med. Andreas Ziegler, 
Prof. Dr. med. Georg F. Hoffmann und Prof. Dr. med. Walter E. Haefeli

Our Vision

The best evidence-based drug therapy for every sick child!

Through designing and conduct of pediatric clinical trials under best expert conditions, we create a valid basis for effective and safe therapy utilizing an extensive range of drugs that are used for prophylaxis and therapy in children.

Our Mission

With pediatric clinical-pharmacological expertise, a specially trained team and an excellent infrastructure, we support the safe translation of new therapeutic compounds into clinical pediatric practice and the promotion of young doctors and non-medical staff careers in this field.
High-quality pediatric clinical trials ensure the safety for trial participants and guarantee valid, reproducible results as a basis for subsequent successful and safe drug use in children and adolescents.


For PatientsClinical trials in children and adolescentsOutpatient aftercare and study unit for children and adolescents with spinal muscular atrophy 

For SponsorsPediatric translational unit paedKliPSGCP-compliant clinical pedriatic drug trials 

For Partners from AcademiaPediatric clinical-pharmacological expertiseImplementation of innovative drug analytical and metabolic
diagnostic methods

(Pharmaco)metabolomicsNon-invasive biochemical pattern recognition for therapy controlSpecific metabolomic “fingerprints” for drug (side) effects 

Child-appropriate drugs 2-dimensional polymer films simplify oral drug administration Individual dosing through 2D drug printing